| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake … JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, ... Clinical Pharmacology & Therapeutics 98 (2), 127-134, 2015 | 959 | 2015 |
| Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update. KTE Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui CH, Yee SW ... Clinical Pharmacology & Therapeutics 93 (4), 324-5, 2013 | 873* | 2013 |
| Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC®) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update JK Hicks, K Sangkuhl, JJ Swen, VL Ellingrod, DJ Müller, K Shimoda, ... Clinical pharmacology and therapeutics 102 (1), 37, 2017 | 615 | 2017 |
| Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic Antidepressants JK Hicks, JJ Swen, CF Thorn, K Sangkuhl, ED Kharasch, VL Ellingrod, ... Clinical Pharmacology & Therapeutics 93 (5), 402-408, 2013 | 583* | 2013 |
| Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLC X Le, S Puri, MV Negrao, MB Nilsson, J Robichaux, T Boyle, JK Hicks, ... Clinical Cancer Research 24 (24), 6195-6203, 2018 | 342 | 2018 |
| Pharmacogenomics and individualized medicine: translating science into practice KR Crews, JK Hicks, CH Pui, MV Relling, WE Evans Clinical Pharmacology & Therapeutics 92 (4), 467-475, 2012 | 306 | 2012 |
| Structure-based classification predicts drug response in EGFR-mutant NSCLC JP Robichaux, X Le, RSK Vijayan, JK Hicks, S Heeke, YY Elamin, HY Lin, ... Nature 597 (7878), 732-737, 2021 | 235 | 2021 |
| Development and use of active clinical decision support for preemptive pharmacogenomics GC Bell, KR Crews, MR Wilkinson, CE Haidar, JK Hicks, DK Baker, ... Journal of the American Medical Informatics Association 21 (e1), e93-e99, 2014 | 229 | 2014 |
| The pharmacogenomics research network translational pharmacogenetics program: overcoming challenges of real‐world implementation AR Shuldiner, MV Relling, JF Peterson, K Hicks, RR Freimuth, W Sadee, ... Clinical Pharmacology & Therapeutics 94 (2), 207-210, 2013 | 192 | 2013 |
| Challenges in CYP2D6 phenotype assignment from genotype data: a critical assessment and call for standardization J Kevin Hicks, J J Swen, A Gaedigk Current drug metabolism 15 (2), 218-232, 2014 | 191 | 2014 |
| REV1 and polymerase ζ facilitate homologous recombination repair S Sharma, JK Hicks, CL Chute, JR Brennan, JY Ahn, TW Glover, ... Nucleic acids research 40 (2), 682-691, 2012 | 159 | 2012 |
| NALP3 inflammasome upregulation and CASP1 cleavage of the glucocorticoid receptor cause glucocorticoid resistance in leukemia cells SW Paugh, EJ Bonten, D Savic, LB Ramsey, WE Thierfelder, P Gurung, ... Nature genetics 47 (6), 607-614, 2015 | 156 | 2015 |
| Clinical Pharmacogenetics Implementation Consortium Guidelines for HLA-B Genotype and Abacavir Dosing: 2014 update. KDL Martin MA, Hoffman JM, Freimuth RR, Klein TE, Dong BJ, Pirmohamed M ... Clinical Pharmacology & Therapeutics 95 (5), 499-500, 2014 | 156 | 2014 |
| Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links JK Hicks, CL Chute, MT Paulsen, RL Ragland, NG Howlett, Q Guéranger, ... Molecular and cellular biology 30 (5), 1217-1230, 2010 | 145 | 2010 |
| Integrating pharmacogenomics into electronic health records with clinical decision support JK Hicks, HM Dunnenberger, KF Gumpper, CE Haidar, JM Hoffman American journal of health-system pharmacy 73 (23), 1967-1976, 2016 | 136 | 2016 |
| A clinician‐driven automated system for integration of pharmacogenetic interpretations into an electronic medical record JK Hicks, KR Crews, JM Hoffman, NM Kornegay, MR Wilkinson, R Lorier, ... Clinical Pharmacology & Therapeutics 92 (5), 563-566, 2012 | 112 | 2012 |
| Implementation of clinical pharmacogenomics within a large health system: from electronic health record decision support to consultation services JK Hicks, D Stowe, MA Willner, M Wai, T Daly, SM Gordon, BA Lashner, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36 (8 …, 2016 | 111 | 2016 |
| Developing knowledge resources to support precision medicine: principles from the Clinical Pharmacogenetics Implementation Consortium (CPIC) JM Hoffman, HM Dunnenberger, J Kevin Hicks, KE Caudle, ... Journal of the American Medical Informatics Association 23 (4), 796-801, 2016 | 111 | 2016 |
| Reactive oxygen nitrogen species decrease cystic fibrosis transmembrane conductance regulator expression and cAMP-mediated Cl− secretion in airway epithelia Z Bebok, K Varga, JK Hicks, CJ Venglarik, T Kovacs, L Chen, ... Journal of biological chemistry 277 (45), 43041-43049, 2002 | 110 | 2002 |
| The IGNITE Pharmacogenetics Working Group: an opportunity for building evidence with pharmacogenetic implementation in a real‐world setting LH Cavallari, AL Beitelshees, KV Blake, LG Dressler, JD Duarte, A Elsey, ... Clinical and translational science 10 (3), 143, 2017 | 88 | 2017 |
Teri E. KleinStanford UniversityVerified email at stanford.edu
